StockMarketWire.com - Citigroup today reaffirms its neutral investment rating on GlaxoSmithKline PLC [LON:GSK] and raised its price target to 1600p (from 1400p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk